DeCEDA/Qrius 2022 was a milestone year for India. India walked into 2022 with an infectious wave of Covid-19 impacting lakhs of people, the wave receded a few weeks into the year. As hopes for a post-pandemic recovery surged, war in Ukraine brought in new challenges for the economy. With supply chains disrupted, global sanctions imposed on Russia, prices of fuel and food shot up. Inflation, already on a high from pent-up...

-The Telegraph Alertness among public and preparedness by healthcare institutions is always good, says Organised Medicine Academic Guild’s secretary-general New Delhi: A body of medics has called on fellow doctors and government agencies to acknowledge India’s largely safe status against existing coronavirus variants and avoid “scaremongering” lest the public disregard caution if and when a “real wolf” arrives. The Organised Medicine Academic Guild (Omag), a body of 15 professional medical associations with a...

-The Telegraph Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market New Delhi: Indian vaccine maker Bharat Biotech announced on Tuesday that its intranasal Covid-19 vaccine, approved by the Centre as a booster dose, would be available at private hospitals for Rs 800 plus additional taxes and service charges per dose. People 18 years or older who have taken two doses of Covaxin, Covishield or any...

-Newsclick.in There is no evidence either of the subvariant being particularly more transmissible than other variants of the Omicron lineage, according to the eminent immunologist. BF.7, the new Omicron subvariant which has triggered a surge in China, has also been detected in India. Till the filing of this article, India hadrecorded only four BF.7 cases. New precautionary measures taken by the government, including advisories on wearing masks in public places and avoiding...

-Hindustan Times Virologist Dr Gagandeep Kang said India does not need restrictions but precautions but China will see a lot of infections like that of India's second wave. Virologist Dr Gagandeep Kang on Friday broke down the current Covid situation in India in comparison with China and said India is doing fine and won't require travel restrictions but China will see 'lots and lots of infections', similar to what India witnessed during...